Corient Private Wealth’s Arrowhead Research ARWR Stock Holding History

Corient Private Wealth’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Sell	16,113 -20,339	-56%	-$1.29M	﹤0.01%	1662
2025 Q4	$2.42M	Buy	36,452 +18,777	+106%	+$920K	﹤0.01%	1425
2025 Q3	$610K	Buy	17,675 +619	+4%	+$13.6K	﹤0.01%	1690
2025 Q2	$269K	Buy	+17,056	New	+$245K	﹤0.01%	2056
2024 Q1	–	Sell	-41,386	Closed	-$1.27M	–	2281
2023 Q4	$1.27M	Sell	41,386 -633	-2%	-$16.8K	﹤0.01%	1197
2023 Q3	$1.13M	Buy	42,019 +605	+1%	+$18.5K	﹤0.01%	1146
2023 Q2	$1.48M	Sell	41,414 -106	-0.3%	-$3.65K	﹤0.01%	1008
2023 Q1	$1.05M	Buy	+41,520	New	+$1.31M	﹤0.01%	1064

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Corient Private Wealth's ARWR Position: Q1 2026 in Review

Corient Private Wealth reduced its Arrowhead Research (ARWR) stake by 56% in Q1 2026, selling an estimated $1.29M and leaving 16,113 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

Corient Private Wealth first reported a position in ARWR in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.42M in Q4 2025. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

Corient Private Wealth held 16,113 shares of Arrowhead Research worth $1.01M as of Q1 2026.
Corient Private Wealth sold 20,339 Arrowhead Research shares in Q1 2026, an estimated $1.29M.
Arrowhead Research made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1662 holding.
Corient Private Wealth first reported a position in Arrowhead Research in Q1 2023 and has held it in 8 quarters since.
Corient Private Wealth's Arrowhead Research position peaked at $2.42M in Q4 2025.
436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.